0001894562-24-000026.txt : 20240607 0001894562-24-000026.hdr.sgml : 20240607 20240607161808 ACCESSION NUMBER: 0001894562-24-000026 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240605 FILED AS OF DATE: 20240607 DATE AS OF CHANGE: 20240607 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gottesdiener Keith Michael CENTRAL INDEX KEY: 0001615856 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41536 FILM NUMBER: 241029709 MAIL ADDRESS: STREET 1: 900 FIFTH AVENUE STREET 2: #8C CITY: NEW YORK STATE: NY ZIP: 10021 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Prime Medicine, Inc. CENTRAL INDEX KEY: 0001894562 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21 ERIE ST. CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-465-0013 MAIL ADDRESS: STREET 1: 21 ERIE ST. CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 wk-form4_1717791477.xml FORM 4 X0508 4 2024-06-05 0 0001894562 Prime Medicine, Inc. PRME 0001615856 Gottesdiener Keith Michael C/O PRIME MEDICINE, INC. 21 ERIE STREET CAMBRIDGE MA 02139 1 1 0 0 See Remarks 0 Common Stock 2024-06-05 4 G 0 250000 0 D 2310837 D Common Stock 2024-06-05 4 G 0 250000 0 A 277166 I By Spouse Common Stock 455334 I By Trust Common Stock 1317741 I By Trust On June 5, 2024, for bona fide estate planning purposes, the Reporting Person transferred 250,000 shares of Issuer common stock to his spouse for no consideration. Shares held by a trust for which certain of the Reporting Person's family member is a trustee. The Reporting Person disclaims beneficial ownership except to the extent of any pecuniary interest therein, and this report shall not be deemed an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose. Shares held by a trust for which the Reporting Person's spouse and certain of the Reporting Person's family member are co-trustees. The Reporting Person disclaims beneficial ownership except to the extent of any pecuniary interest therein, and this report shall not be deemed an admission that such shares are beneficially owned by the Reporting Person for Section 16 or any other purpose. President and Chief Executive Officer /s/ Karen Brown, attorney-in-fact 2024-06-07